Compared to injectable peptides, this oral bioavailability offers a practical and non-invasive mode of delivery, which is a major benefit
There is minimal to no downtime
A 2025 systematic review published in Orthopaedic Journal of Sports Medicine , covering 36 studies from 1993 to 2024, found that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved outcomes across muscle, tendon, ligament, and bone injury models in animals.4 The peptide enhances growth hormone receptor expression in tendon fibroblasts a key mechanism for tissue repair and regeneration.5 In the only published human orthopaedic data, seven of twelve patients with chronic knee pain reported relief lasting more than six months after a single BPC-157 injection.4 That is a small sample
Each strip dissolves quickly and completely, which supports uniform exposure across repeated trials
Its usually done in the deltoid, vastus lateralis, or gluteal muscles
They are research context, not proven human dosing